Gynecologie Obstetrique & Fertilite最新文献

筛选
英文 中文
Cancer du sein et Big Data : évolution ou révolution ? 乳腺癌与大数据:进化还是革命?
Gynecologie Obstetrique & Fertilite Pub Date : 2016-07-01 DOI: 10.1016/j.gyobfe.2016.05.011
C. Mathelin MD, PhD, K. Neuberger, I. Ibnouhsein
{"title":"Cancer du sein et Big Data : évolution ou révolution ?","authors":"C. Mathelin MD, PhD, K. Neuberger, I. Ibnouhsein","doi":"10.1016/j.gyobfe.2016.05.011","DOIUrl":"https://doi.org/10.1016/j.gyobfe.2016.05.011","url":null,"abstract":"","PeriodicalId":55077,"journal":{"name":"Gynecologie Obstetrique & Fertilite","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gyobfe.2016.05.011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91626305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Morcellement utérin : controverses actuelles et futurs développements 子宫分裂:当前的争议和未来的发展
Gynecologie Obstetrique & Fertilite Pub Date : 2016-07-01 DOI: 10.1016/j.gyobfe.2016.05.006
Y. Kerbage , H. Azaïs , J.P. Estevez , B. Merlot , P. Collinet
{"title":"Morcellement utérin : controverses actuelles et futurs développements","authors":"Y. Kerbage ,&nbsp;H. Azaïs ,&nbsp;J.P. Estevez ,&nbsp;B. Merlot ,&nbsp;P. Collinet","doi":"10.1016/j.gyobfe.2016.05.006","DOIUrl":"10.1016/j.gyobfe.2016.05.006","url":null,"abstract":"<div><p>Modern surgery tends to the improvement of minimally invasive strategies. Laparoscopy, rooted in practices for years, supplanted laparotomy in many directions. Regarding the extraction of large uterus, morcellation is currently the only way to externalize surgical specimens (myomas, uterine), without increasing the skin opening while allowing to reduce postoperative complications compared to laparotomy. However, in 2014, the Food and Drug Administration (FDA) discourages the use of uterine morcellation because of oncological risk. This recommendation has been challenged by a part of the profession. Our review has sought to identify the evidence for and against the use of morcellation. We also tried to quantify surgical risk and the current means of prevention. The incidence of uterine sarcomas is still poorly identified and preoperative diagnostic facilities remain inadequate. The small number of retrospective studies currently available could not enable any recommendation. The evaluation of morcellation devices and the improvement of preoperative diagnosis modalities (imaging, preoperative biopsy) are to continue to minimize the oncological risk.</p></div>","PeriodicalId":55077,"journal":{"name":"Gynecologie Obstetrique & Fertilite","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gyobfe.2016.05.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34625617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
État des lieux de l’utilisation du sulfate de magnésium à visée neuroprotectrice au CHU de Rouen 鲁昂大学用于神经保护目的的硫酸镁的使用情况
Gynecologie Obstetrique & Fertilite Pub Date : 2016-07-01 DOI: 10.1016/j.gyobfe.2016.05.008
J.-C. Millochau , S. Marret , S. Oden , E. Verspyck
{"title":"État des lieux de l’utilisation du sulfate de magnésium à visée neuroprotectrice au CHU de Rouen","authors":"J.-C. Millochau ,&nbsp;S. Marret ,&nbsp;S. Oden ,&nbsp;E. Verspyck","doi":"10.1016/j.gyobfe.2016.05.008","DOIUrl":"10.1016/j.gyobfe.2016.05.008","url":null,"abstract":"<div><h3>Objectives</h3><p>Although the benefit of magnesium sulfate to prevent cerebral palsy in antenatal on very preterm infants has been shown, there is still reluctance to use it. The aim of this study was to conduct an assessment of our practice using magnesium sulfate to prevent cerebral palsy at Rouen University Hospital to report its feasibility and safety in order to spread its use.</p></div><div><h3>Methods</h3><p>Unicentric and retrospective study, at the University Hospital of Rouen, between January and June 2014. All patients who delivered before 33 weeks or considered at risk of imminent delivery before 33 weeks were included (<em>n</em> <!-->=<!--> <!-->86).</p></div><div><h3>Results</h3><p>Among the patients who delivered before 33 weeks (<em>n</em> <!-->=<!--> <!-->82), a magnesium sulfate loading dose was administrated in 91.5% of cases. Treatment was mainly established and monitored by midwives (98.6%), usually in the delivery room (82.4%), and with an average duration of administration of 8.9<!--> <!-->±<!--> <!-->17.5<!--> <!-->hours. The treatment had to be stopped in a patient who presented bradypnea associated with impaired consciousness.</p></div><div><h3>Conclusion</h3><p>Our study shows that magnesium sulfate can easily be prescribed in clinical practice.</p></div>","PeriodicalId":55077,"journal":{"name":"Gynecologie Obstetrique & Fertilite","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gyobfe.2016.05.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34676442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comment je fais… l’injection in situ de méthotrexate dans le traitement d’une grossesse myométriale 我该怎么做…甲氨蝶呤原位注射治疗肌层妊娠
Gynecologie Obstetrique & Fertilite Pub Date : 2016-07-01 DOI: 10.1016/j.gyobfe.2016.06.011
K. Kolanska, J. Cohen, A.S. Zanini-Grandon, J. Belghiti, M. Bornes, E. Daraï
{"title":"Comment je fais… l’injection in situ de méthotrexate dans le traitement d’une grossesse myométriale","authors":"K. Kolanska,&nbsp;J. Cohen,&nbsp;A.S. Zanini-Grandon,&nbsp;J. Belghiti,&nbsp;M. Bornes,&nbsp;E. Daraï","doi":"10.1016/j.gyobfe.2016.06.011","DOIUrl":"10.1016/j.gyobfe.2016.06.011","url":null,"abstract":"","PeriodicalId":55077,"journal":{"name":"Gynecologie Obstetrique & Fertilite","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gyobfe.2016.06.011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34677490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of long-term pelvic floor symptoms after an obstetric anal sphincter injury (OASI) at least one year after delivery: A retrospective cohort study of 159 cases 产后至少一年产科肛门括约肌损伤(OASI)后长期盆底症状的评估:一项159例回顾性队列研究
Gynecologie Obstetrique & Fertilite Pub Date : 2016-07-01 DOI: 10.1016/j.gyobfe.2016.05.007
D. Desseauve , S. Proust , C. Carlier-Guerin , C. Rutten , F. Pierre , X. Fritel
{"title":"Evaluation of long-term pelvic floor symptoms after an obstetric anal sphincter injury (OASI) at least one year after delivery: A retrospective cohort study of 159 cases","authors":"D. Desseauve ,&nbsp;S. Proust ,&nbsp;C. Carlier-Guerin ,&nbsp;C. Rutten ,&nbsp;F. Pierre ,&nbsp;X. Fritel","doi":"10.1016/j.gyobfe.2016.05.007","DOIUrl":"10.1016/j.gyobfe.2016.05.007","url":null,"abstract":"<div><h3>Objectives</h3><p>The aim of this study was to assess long-term pelvic floor symptoms after an obstetric anal sphincter injury (OASI).</p></div><div><h3>Methods</h3><p>This retrospective cohort study included 237 cases of OASI (0.86% of deliveries) identified at Poitiers University Hospital between 2000 and 2011. Symptoms were assessed using validated self-administered questionnaires, including Female Pelvic Floor Questionnaire, Pescatori anal incontinence score, EuroQoL five-dimension score, and pain visual analogue scale (VAS).</p></div><div><h3>Results</h3><p>One hundred and sixty women (67%) filled out the questionnaires, on average 46 months after delivery (8–152). Among them, 93 (54%) reported at least one symptom occurring “frequently” (the most common being dyspareunia), and 45 (28%) a symptom occurring “daily” (the most common being flatus incontinence). Anal incontinence was reported by 32 (20%) women, flatus incontinence “frequently” or “daily” by 28 (18%), and stool incontinence “frequently” or “daily” by 9 (6%). Urinary incontinence was reported “frequently” or “daily” by 27 women (17%) at stress, 17 (11%) at urge, and 11 (7%) at mixed circumstances. Prolapse symptoms were reported “frequently” or “daily” by 6 women (4%). Pain during intercourse was reported “frequently” or “daily” by 17 women (11%). Twenty-four women (18%) reported chronic pelvic pain (VAS score<!--> <!-->≥<!--> <!-->4/10). Ninety-five percent of women reported a normal quality of life for mobility, self-care, and usual activities; however, alterations in pain/discomfort (32%) and anxiety/depression (33%) domains were frequently reported.</p></div><div><h3>Conclusion</h3><p>Pelvic floor symptoms 4 years after OASI were highly prevalent.</p></div>","PeriodicalId":55077,"journal":{"name":"Gynecologie Obstetrique & Fertilite","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gyobfe.2016.05.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34697697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 27
Est-il utile d’observer les embryons aux stades précoces de leur développement quand une culture prolongée est effectuée ? Oui 当进行长时间的培养时,观察胚胎发育的早期阶段是否有用?是的
Gynecologie Obstetrique & Fertilite Pub Date : 2016-07-01 DOI: 10.1016/j.gyobfe.2016.06.002
C. Sifer
{"title":"Est-il utile d’observer les embryons aux stades précoces de leur développement quand une culture prolongée est effectuée ? Oui","authors":"C. Sifer","doi":"10.1016/j.gyobfe.2016.06.002","DOIUrl":"10.1016/j.gyobfe.2016.06.002","url":null,"abstract":"","PeriodicalId":55077,"journal":{"name":"Gynecologie Obstetrique & Fertilite","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gyobfe.2016.06.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34697695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Traitements hormonaux de la ménopause et risques de cancers 更年期激素治疗和癌症风险
Gynecologie Obstetrique & Fertilite Pub Date : 2016-07-01 DOI: 10.1016/j.gyobfe.2016.05.012
A. Lasserre , A. Fournier
{"title":"Traitements hormonaux de la ménopause et risques de cancers","authors":"A. Lasserre ,&nbsp;A. Fournier","doi":"10.1016/j.gyobfe.2016.05.012","DOIUrl":"10.1016/j.gyobfe.2016.05.012","url":null,"abstract":"<div><p>Estrogen-progestagen menopausal hormonal therapy (MHT) is recognized as carcinogenic to humans. The article presents the associations between MHT and breast, ovary and endometrial cancer risks, in particular according to treatment modalities. If MHT must be prescribed, it is recommended to use the lowest dose for the shortest possible duration. Discussing with the patient the benefits but also the risks and making regular gynecological follow-up are strongly encouraged.</p></div>","PeriodicalId":55077,"journal":{"name":"Gynecologie Obstetrique & Fertilite","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gyobfe.2016.05.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34698705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Performance de l’échographie dans l’estimation du poids fœtal à terme 超声在估计足月胎儿体重方面的表现
Gynecologie Obstetrique & Fertilite Pub Date : 2016-07-01 DOI: 10.1016/j.gyobfe.2016.05.005
M. Lafont, P. Dellinger, W. Mutumba, C. Bernard, T. Hoyek
{"title":"Performance de l’échographie dans l’estimation du poids fœtal à terme","authors":"M. Lafont,&nbsp;P. Dellinger,&nbsp;W. Mutumba,&nbsp;C. Bernard,&nbsp;T. Hoyek","doi":"10.1016/j.gyobfe.2016.05.005","DOIUrl":"10.1016/j.gyobfe.2016.05.005","url":null,"abstract":"<div><h3>Objectives</h3><p>Our aim was to evaluate the accuracy of estimated fetal weight (EFW) by ultrasound at due date and the factors that could affect it.</p></div><div><h3>Methods</h3><p>We performed a retrospective study of 233 patients in 2014. An ultrasound was performed at due date consultation around 41 weeks of amenorrhea by midwives sonographer. EFW was calculated using the Hadlock's formula with 3 parameters (biparietal diameter, abdominal circumference and femur length) and then adjusted including the growth from the due date consultation to the day of delivery (25<!--> <!-->g/day) and finally compared to birth weight (BW).</p></div><div><h3>Results</h3><p>The mean absolute weight difference between EFW adjusted and BW was 256<!--> <!-->g [0; 910]. The mean absolute percentage error was 7.2 % [0; 24.5] and the proportion of the EFW adjusted within 10 % of BW was 69.1 %. There was a strong correlation between EFW adjusted and BW (R<!--> <!-->=<!--> <!-->0.79). Obesity in early pregnancy or childbirth, excessive weight gain, the presence of oligoanamnios and fetal macrosomia had no influence on the estimated fetal weight. Indeed, the mean absolute percentage error of child who were macrosome and those were not, was similars (7.9 % vs 7.1 %, <em>P</em> <!-->=<!--> <!-->0.407).</p></div><div><h3>Conclusions</h3><p>EFW by ultrasound at due date is performant. However, the adjustment by the effect growth does not improve accuracy. Fetal macrosomia do not decrease the accuracy of ultrasound to estimate the fetal weight at term.</p></div>","PeriodicalId":55077,"journal":{"name":"Gynecologie Obstetrique & Fertilite","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gyobfe.2016.05.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34677489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
État des lieux de la salpingectomie prophylatique en France 法国预防性输卵管切除术的现状
Gynecologie Obstetrique & Fertilite Pub Date : 2016-07-01 DOI: 10.1016/j.gyobfe.2016.05.003
G. Chene , B. de Rochambeau , K. Le Bail-Carval , E. Beaufils , P. Chabert , G. Mellier , G. Lamblin
{"title":"État des lieux de la salpingectomie prophylatique en France","authors":"G. Chene ,&nbsp;B. de Rochambeau ,&nbsp;K. Le Bail-Carval ,&nbsp;E. Beaufils ,&nbsp;P. Chabert ,&nbsp;G. Mellier ,&nbsp;G. Lamblin","doi":"10.1016/j.gyobfe.2016.05.003","DOIUrl":"10.1016/j.gyobfe.2016.05.003","url":null,"abstract":"<div><h3>Objectives</h3><p>Since the recent evidence of a tubal origin of most ovarian cancers, opportunistic salpingectomy could be discussed as a prophylactic strategy in the general population and with hereditary predisposition. We aimed to survey French gynecological surgeons about their current surgical practice of prophylactic salpingectomy.</p></div><div><h3>Methods</h3><p>An anonymous online survey was sent to French obstetrician-gynaecologists and gynecological surgeons. There were 13 questions about their current clinical practice and techniques of salpingectomy during a benign hysterectomy or as a tubal sterilization method, salpingectomy versus salpingo-oophorectomy in the population with genetic risk, salpingectomy in relationship with endometriosis and questions including histopathological considerations.</p></div><div><h3>Results</h3><p>Among the 569 respondents, opportunistic salpingectomy was always performed between 42.48% and 43.44% during laparoscopic, laparoscopic-assisted vaginal or laparotomic hysterectomy and only 12.26% in case of vaginal route. In the genetic population, salpingo-oophorectomy was mainly performed. Tubal sterilization was often practiced by the hysteroscopic route. More than 90% of respondents didn’t perform salpingectomy in case of endometriosis. There was not any specific tubal histopathological protocol in 71.54% of cases.</p></div><div><h3>Conclusions</h3><p>Salpingectomy may be a preventing strategy in the low- and high-risk population. The survey's responses show that salpingectomy seems to be a current practice during benign hysterectomy for more than 40% doctors. However, there is not any change with no more salpingectomy in the population with genetic risk, or in case of endometriosis or tubal sterilization.</p></div>","PeriodicalId":55077,"journal":{"name":"Gynecologie Obstetrique & Fertilite","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gyobfe.2016.05.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34625621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Révélation tardive d’une tumeur du site d’implantation placentaire 胎盘着床部位肿瘤的晚期发现
Gynecologie Obstetrique & Fertilite Pub Date : 2016-07-01 DOI: 10.1016/j.gyobfe.2016.05.004
M. Lodi , A.-J. Carin , C.Y. Akaladios , V. Gabriele , O. Garbin
{"title":"Révélation tardive d’une tumeur du site d’implantation placentaire","authors":"M. Lodi ,&nbsp;A.-J. Carin ,&nbsp;C.Y. Akaladios ,&nbsp;V. Gabriele ,&nbsp;O. Garbin","doi":"10.1016/j.gyobfe.2016.05.004","DOIUrl":"10.1016/j.gyobfe.2016.05.004","url":null,"abstract":"","PeriodicalId":55077,"journal":{"name":"Gynecologie Obstetrique & Fertilite","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gyobfe.2016.05.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34609537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信